Patients with acute MI were randomized in 1:1 fashion to receive spironolactone 25 mg daily (n = 3,537) or placebo (n = 3,525) following PCI, preferably with the Boston Scientific SYNERGY ...

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

As a beauty journalist, I can offer recommendations for the best mascaras without skipping a beat. Struggling with melasma? I ...

No Difference in Primary Outcome CLEAR SYNERGY (OASIS 9) is a 2 x 2 randomized controlled trial of low-dose colchicine 0.5 mg daily versus placebo and spironolactone 25 mg daily versus placebo in ...

Trichologist Kari Williams, Ph.D, explains that whether you're 25 or 55, seeing your hair disappear can feel ... can also ...

She was taking maximally tolerated, guideline-directed medical therapy of oral sacubitril–valsartan (49 mg and 51 mg, respectively, twice daily), oral bisoprolol (10 mg/d), oral spironolactone (25 ...

There are four supplements containing a combination (but not all) of these ingredients: finasteride, minoxidil, vitamin D3, ...

While the FDA hasn’t approved oral minoxidil for hair loss, clinical trials have shown it’s quite effective for hair growth at various doses (0.25 to 2.5 mg daily). Spironolactone. For those ...

Both groups were then randomized again to receive spironolactone or placebo ... The trial was designed with 80% power to detect a 25% relative risk reduction in the primary outcome (9% estimated ...